Precision Optics (POCI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
20 Jan, 2026Executive summary
FY2024 revenue was $19.1M, down from $21.0M in FY2023 but slightly above guidance, with declines in optical components and finished products partially offset by record engineering design services revenue.
Product development/engineering revenue hit a record $8.3M, up 24% year-over-year, helping offset lost business and program discontinuations.
Net loss widened to $3.0M ($0.49/share) from $0.14M in FY2023, driven by lower revenues and gross profit.
Operational investments included new engineering hires, a new VP of Sales and Marketing, ERP system implementation, and manufacturing consolidation.
The company raised $1.2M–$1.4M in equity post-year-end and received a lender waiver after missing a debt covenant.
Financial highlights
FY2024 revenue: $19.1M (down 6.6%–9.2% year-over-year, excluding prior year’s $600K one-time license revenue).
Gross margin for the year: 30.3% (vs. 36.8% prior year, or 34.9% adjusted for one-time item); Q4 gross margin: 21.7%–22%.
Net loss for FY2024: $2.95M–$3.0M; Q4 net loss: $1.4M.
Adjusted EBITDA: negative $1.6M for the year (vs. positive $491K prior year); Q4 adjusted EBITDA: negative $1.1M.
Cash at June 30, 2024: $0.4M, down from $2.9M prior year; $1.2M–$1.4M raised in equity post-year-end.
Outlook and guidance
Q1 FY2025 revenue expected between $4.2M and $4.4M, flat year-over-year due to lingering program delays.
Double-digit revenue growth projected for FY2025, with significant increases starting Q2 and record quarterly revenues expected before year-end.
Adjusted EBITDA breakeven targeted at quarterly revenue of ~$5.5M, expected in Q2 and beyond.
Ross Optical division and optical components expected to rebound as industry conditions improve in 2025.
Latest events from Precision Optics
- Record revenue growth offset by margin compression and liquidity risks.POCI
Q2 202617 Feb 2026 - Shareholders will vote on director elections, executive pay, and auditor ratification at the 2025 meeting.POCI
Proxy Filing3 Feb 2026 - Votes will be cast on director elections, executive pay, and auditor ratification at the 2026 meeting.POCI
Proxy Filing2 Feb 2026 - Annual meeting to elect directors, approve executive pay, and ratify auditor, with strong governance.POCI
Proxy Filing2 Feb 2026 - Strong product pipeline and new production ramp-ups set the stage for record growth in 2025.POCI
Lytham Partners Fall 2024 Investor Conference19 Jan 2026 - Net loss widened on lower revenue and margin, but growth is expected as new programs scale.POCI
Q1 202514 Jan 2026 - Single-use endoscopes and the Unity platform are fueling rapid growth and production expansion.POCI
Lytham Partners 2025 Industrials & Basic Materials Investor Summit26 Dec 2025 - Production revenue surged 42% sequentially, with Unity Imaging Platform launch fueling optimism.POCI
Q2 202524 Dec 2025 - Shelf registration allows up to $75M in securities to fund growth amid ongoing losses and supply risks.POCI
Registration Filing16 Dec 2025